Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Astrana Health | ASTH | Nov 29, 2024 | 43.25 | +0.91 |
AstraZeneca ADR | AZN | Nov 29, 2024 | 67.62 | +0.63 |
Astria Therapeutics | ATXS | Nov 29, 2024 | 10.39 | -1.05 |
Astronics | ATRO | Nov 29, 2024 | 16.15 | +0.69 |
AstroNova | ALOT | Nov 29, 2024 | 15.37 | +2.33 |
Astrotech | ASTC | Nov 29, 2024 | 7.10 | -4.70 |
Asure Software | ASUR | Nov 29, 2024 | 9.79 | -0.31 |
AT&T | T | Nov 29, 2024 | 23.16 | -0.47 |
AT&T A Pref | T-A | Nov 29, 2024 | 21.43 | +0.33 |
AT&T C Pref | T-C | Nov 29, 2024 | 20.17 | -0.05 |
ATA Creativity Global ADR | AACG | Nov 29, 2024 | 1.00 | -0.17 |
Atai Life Sciences BV | ATAI | Nov 29, 2024 | 1.78 | +2.89 |
Atara Biotherapeutics | ATRA | Nov 29, 2024 | 12.18 | -0.04 |
Atea Pharmaceuticals | AVIR | Nov 29, 2024 | 3.42 | -1.16 |
Aterian | ATER | Nov 29, 2024 | 2.73 | +1.11 |
Athena Technology Acquisition II | ATEK | Nov 29, 2024 | 11.92 | +0.93 |
Athene A Pref | ATH-A | Nov 29, 2024 | 25.70 | +2.27 |
Athene B Pref | ATH-B | Nov 29, 2024 | 22.49 | +2.60 |
Athene C Pref | ATH-C | Nov 29, 2024 | 25.30 | -0.08 |
Athene D Pref | ATH-D | Nov 29, 2024 | 19.74 | +3.19 |
Athene Holding | ATH-E | Nov 29, 2024 | 27.34 | +1.67 |
Athira Pharma | ATHA | Nov 29, 2024 | 0.66 | +0.34 |
Ati Physical Therapy A | ATIP | Nov 29, 2024 | 1.53 | -8.38 |
ATIF Holdings | ATIF | Nov 29, 2024 | 0.65 | +4.84 |
Atkore | ATKR | Nov 29, 2024 | 94.31 | +1.22 |
Atlanta Braves A | BATRA | Nov 29, 2024 | 42.09 | +0.33 |
Atlanta Braves C | BATRK | Nov 29, 2024 | 40.35 | +0.52 |
Atlantic American | AAME | Nov 29, 2024 | 1.52 | -2.56 |
Atlantic Coastal Acquisition II A | ACAB | Nov 29, 2024 | 5.77 | 0.00 |
Atlantic Union Bank | AUB | Nov 29, 2024 | 42.43 | +0.45 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.